Fresenius Medical Care AG (XETR:FME) Share Price

Company Profile

Business description
Fresenius Medical Care is the largest dialysis company in the world, treating over 300,000 patients from roughly 3,750 clinics across the globe as of mid-2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market and benefits from being the world's only fully integrated dialysis business. Services account for roughly 80% of firmwide revenue, including care coordination and ancillary operations, while products account for the other roughly 20%.
Contact
Else-Kroener-Strasse 1
Bad HomburgHE61352
DEU
T: +49 791033353
E: robert.adolph(at)fmc-ag.com
https://www.freseniusmedicalcare.com
Sector
Healthcare
Stock type
Defensive
Industry
Medical Care Facilities
Fiscal Year End
31 December 2025
Employees
113,079

Recommended

Watching the data centre business and the debate around it, here’s what we think of Nvidia stock.

Morningstar | 25 February 2025

These two ASX shares are trading at a discount to our fair value.

Morningstar | 24 February 2025

Board members step down over differences on the role of former CEO Richard White.

Roy van Keulen | 24 February 2025

Index	Last price	Change	% Change
All Ordinaries	8,498.00	62.10	-0.73%
CAC 40	8,051.07	39.92	-0.49%
DAX 40	22,410.27	15.66	-0.07%
Dow JONES (US)	43,491.26	30.05	0.07%
FTSE 100	8,668.67	9.69	0.11%
HKSE	23,034.02	307.59	-1.32%
NASDAQ	19,011.27	275.65	-1.43%
Nikkei 225	38,237.79	539.15	-1.39%
NZX 50 Index	12,307.27	224.45	-1.79%
S&P 500	5,944.79	38.46	-0.64%
S&P/ASX 200	8,251.90	56.30	-0.68%
SSE Composite Index	3,346.04	26.99	-0.80%